Results 101 to 110 of about 12,907 (206)

Dipeptidyl peptidase IV regulates proliferation of preglomerular vascular smooth muscle and mesangial cells [PDF]

, 2012
—The purpose of this study was to investigate the role of dipeptidyl peptidase IV in regulating the effects of 2 of its substrates, neuropeptide Y1-36 and peptide YY1-36, on proliferation of and collagen production by preglomerular vascular smooth muscle
Stanton J. Kochanek, Edwin K. Jackson, Delbert G. Gillespie   +2 more
core  

Inhibitors of Dipeptidyl Peptidase IV and Aminopeptidase N Target Major Pathogenetic Steps in Acne Initiation [PDF]

, 2007
Acne is a chronic disease hallmarked by sebaceous hyperplasia, follicular hyperkeratosis, and inflammation. Parallel targeting of these factors is required to treat acne effectively. Inhibitors of dipeptidyl peptidase IV (DP IV) and aminopeptidase N (APN)
Bank, Ute, Faust, Jürgen, Wrenger, Sabine, Gollnick, Harald, Zouboulis, Christos C., Vetter, Robert, Reinhold, Dirk, Wiswedel, Ingrid, Kähne, Thilo, Lendeckel, Uwe, Thielitz, Anja, Hartig, Roland, Neubert, Klaus, Helmuth, Martin, Ansorge, Siegfried   +14 more
core   +1 more source

The Potential Role of Cyclopeptides from Pseudostellaria heterophylla, Linum usitatissimum and Drymaria diandra, and Peptides Derived from Heterophyllin B as Dipeptidyl Peptidase IV Inhibitors for the Treatment of Type 2 Diabetes: An In Silico Study. [PDF]

Metabolites, 2022
Liao HJ, Tzen JTC.
europepmc   +1 more source

Glucagon-like peptide 1 and inhibitors of dipeptidyl peptidase IV in the treatment of type 2 diabetes mellitus. [PDF]

, 2004
Udgivelsesdato: 2004-DecProof-of-concept for the efficacy of a glucagon-like peptide 1 (GLP-1)-based therapy of patients with type 2 diabetes was provided in 2002 by means of prolonged continuous subcutaneous infusion of native GLP-1. Since then, several
Holst, Jens Juul, Deacon, Carolyn F
core   +1 more source

Exploring the dipeptidyl peptidase-IV inhibitory potential of probiotic-fermented milk: An in vitro and in silico comprehensive investigation into peptides from milk of different farm animals

Journal of Dairy Science
: Bioactive peptides produced via enzymatic hydrolysis have been widely investigated for their dipeptidyl peptidase-IV (DPP-IV) inhibitory properties.
Priti Mudgil, Chee-Yuen Gan, Pei-Gee Yap, Ali Ali Redha, Reem H. Sultan Alsaadi, Khaja Mohteshamuddin, José E. Aguilar-Toalá, Abraham M. Vidal-Limon, Andrea M. Liceaga, Sajid Maqsood   +9 more
doaj   +1 more source

The perceptions of natural compounds against dipeptidyl peptidase 4 in diabetes: from to

Therapeutic Advances in Chronic Disease, 2019
Dipeptidyl peptidase IV (DPP-4), an incretin glucagon-like peptide-1 (GLP-1) degrading enzyme, contains two forms and it can exert various physiological functions particular in controlling blood glucose through the action of GLP-1.
Shian-Ren Lin, Chia-Hsiang Chang, May-Jwan Tsai, Henrich Cheng, Jian-Chyi Chen, Max K. Leong, Ching-Feng Weng   +6 more
doaj   +1 more source

Use of Dipeptidyl-Peptidase IV Inhibitors and Bullous Pemphigoid [PDF]

Dermatology, 2017
Schaffer, Clara, Buclin, Thierry, Jornayvaz, François, Cazzaniga, Simone, Borradori, Luca, Gilliet, Michel, Feldmeyer, Laurence   +6 more
openaire   +3 more sources

Exploring the clinical utility of DPP-IV and SGLT2 inhibitors in papillary thyroid cancer: a literature review

Frontiers in Pharmacology
In the realm of clinical management, Papillary Thyroid Cancer (PTC) stands out as a prevalent thyroid malignancy, characterized by significant metabolic challenges, particularly in the context of carbohydrate metabolism.
Angelika Buczyńska, Maria Kościuszko, Adam Jacek Krętowski, Adam Jacek Krętowski, Anna Popławska-Kita   +4 more
doaj   +1 more source

In-Vitro Studies on Selected Jordanian Plants as Dipeptidyl Peptidase-IV Inhibitors for Management of Diabetes Mellitus. [PDF]

Iran J Pharm Res, 2020
Sewidan N, Abu Khalaf R, Mohammad H, Hammad W.   +3 more
europepmc   +1 more source

A comprehensive study of ground-roasted coffee beans from Coffea liberica as dipeptidyl peptidase IV inhibitors

European Pharmaceutical Journal
Type 2 diabetes mellitus (T2DM), a degenerative disease characterized by insulin resistance, has been reported as a serious healthcare problem, especially in low-to-middle-income countries.
Riswanto Florentinus Dika Octa, Adventra Nicolaus De Deo, Priyambodo Gregorius Seno, Kusraynaldi Titus Marcel, Br Sembiring Angel Yemima Srininta, Larasati Theresia Niken, Windarsih Anjar, Wira Waskitha Stephanus Satria, Gani Michael Raharja, Istyastono Enade Perdana   +9 more
doaj   +1 more source